299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,696 / Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00803179 (ClinicalTrials.gov)	November 2008	4/12/2008	Growth Hormone Therapy for Wasting in Cystic Fibrosis	Growth Hormone Therapy for Wasting in Cystic Fibrosis	Cystic Fibrosis	Drug: Nutropin AQ	University of Massachusetts, Worcester	NULL	Terminated	18 Years	N/A	All	5	Phase 1	United States
2	NCT00079742 (ClinicalTrials.gov)	September 2003	11/3/2004	A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis	A Phase II, Multicenter, Randomized, Controlled, Open-Label Study of the Safety and Efficacy of Nutropin AQ [Somatropin (DNA Origin) Injection] for the Treatment of Growth Restriction in Children With Cystic Fibrosis	Cystic Fibrosis	Drug: Nutropin AQ [somatropin (DNA origin) injection]	Genentech, Inc.	NULL	Completed	5 Years	13 Years	Both	68	Phase 2	United States
3	NCT00256555 (ClinicalTrials.gov)	February 2000	17/11/2005	Growth Hormone Treatment Study in Children With Cystic Fibrosis	GROWTH HORMONE USE IN CYSTIC FIBROSIS - A MULTICENTER STUDY	Cystic Fibrosis	Drug: Nutropin AQ	University of Texas Southwestern Medical Center	Genentech, Inc.	Withdrawn	5 Years	12 Years	All	0	Phase 2/Phase 3	NULL